-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
SAB Biotherapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2020 to Q1 2025.
- SAB Biotherapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$7.8M, a 27.5% increase year-over-year.
- SAB Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$34.3M, a 36.5% decline from 2023.
- SAB Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$25.1M, a 7.08% decline from 2022.
- SAB Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$23.5M, a 1281% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)